Call for Papers: Journal of Commercial Biotechnology

The Journal of Commercial Biotechnology is looking for some fresh voices.

Journal of Commercial Biotechnology is an international peer-reviewed, professional journal which focuses on the commercial, legal and regulatory issues affecting biotech, biopharmaceutical, agrochemical and environmental companies. Organizations whose representatives have demonstrated their expertise in recent issues include Genzyme, Merck, GlaxoSmithKline, KPMG, Ernst & Young, Deutsche Bank, Amgen Inc and Datamonitor Healthcare.

Details of the journal’s readership, aims and scope, Editorial Board and instructions for authors can be found at www.palgrave-journals.com/jcb where you will also find a free online sample issue. Articles tend to range between 2,500 and 5,000 words in length although quality is more important than quantity.

If you would like to make a submission, drop me a line.